Novel folated Pluronic/poly(lactic acid) nanoparticles for targeted delivery of paclitaxel
- 25 May 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (58) , 52729-52738
Abstract
The purpose of this study was to explore the in vitro and in vivo targeting behaviors of novel folated Pluronic/poly(lactic acid) block copolymers (FA–Pluronic–PLA) for the anticancer drug, paclitaxel. Both paclitaxel-loaded FA–Pluronic–PLA nanoparticles show in vitro sustained release and in vivo prolonged circulation time. The in vitro actively targeting behavior of paclitaxel-loaded FA–Pluronic–PLA nanoparticles against OVCAR-3 cells (folate receptor positive) was proved by the cytotoxicity tests. The in vivo targeting properties of nanoparticles were also studied in OVCAR-3 ovarian tumor-bearing mice. It was observed that the tumor growth percentage for targeted paclitaxel-loaded FA–F127–PLA nanoparticles is lower than that for non-targeted paclitaxel-loaded PLA–F127–PLA nanoparticles. It was observed from FM images that FA–Pluronic–PLA nanoparticles are mainly localized within the cytoplasm of OVCAR-3 cells.Keywords
This publication has 44 references indexed in Scilit:
- Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cellsInternational Journal of Pharmaceutics, 2016
- Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(d,l-lactic acid)Acta Biomaterialia, 2016
- Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectivesJournal of Controlled Release, 2015
- Cancer nanomedicine: from targeted delivery to combination therapyTrends in Molecular Medicine, 2015
- Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxelColloids and Surfaces B: Biointerfaces, 2014
- Combinational Delivery of Hydrophobic and Hydrophilic Anticancer Drugs in Single Nanoemulsions To Treat MDR in CancerMolecular Pharmaceutics, 2014
- Paclitaxel-loaded PCL–TPGS nanoparticles: In vitro and in vivo performance compared with Abraxane®Colloids and Surfaces B: Biointerfaces, 2014
- Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticlesBiomaterials, 2013
- The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistanceInternational Journal of Nanomedicine, 2013
- Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticlesBiomaterials, 2012